
    
      Four adults with proven EPP volunteered as subjects for this study. First period: Subjects
      received 1 gm colestipol twice daily for ~45 days, then 2 gm twice daily for ~45 days. Labs
      included CBC; liver chemistries including cholesterol; serum iron, TIBC and ferritin;
      erythrocyte and plasma protoporphyrin concentrations; and completion of sun exposure
      questionnaire focused on cutaneous manifestations every 2-4 weeks. Second period: Subjects
      received colestipol tablets, 2 grams twice daily, completing the sun exposure questionnaire
      and protoporphyrin determinations ~monthly for 5-6 months.
    
  